Gene · 2057
Papers3,982
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,982
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The cytokine receptor CRLF3 is a human neuroprotective EV-3 (Epo) receptor. | Front Mol Neurosci | 2023 | 37168680 | PubTator, text mining | PubMed |
| 'Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting. | Br J Cancer | 2023 | 37156894 | PubTator, text mining | PubMed |
| The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma. | Sci Rep | 2023 | 37147361 | PubTator, text mining | PubMed |
| Comparative analyses of bat genomes identify distinct evolution of immunity in Old World fruit bats. | Sci Adv | 2023 | 37146151 | PubTator, text mining | PubMed |
| Identification of bicalutamide resistance-related genes and prognosis prediction in patients with prostate cancer. | Front Endocrinol (Lausanne) | 2023 | 37143720 | PubTator, text mining | PubMed |
| Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant-review article. | Ann Hematol | 2023 | 37129698 | PubTator, text mining | PubMed |
| Novel pharmacological and dietary approaches to target mTOR in B-cell acute lymphoblastic leukemia. | Front Oncol | 2023 | 37124486 | PubTator, text mining | PubMed |
Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors versus erythropoiesis-stimulating agents on iron metabolism and inflammation in patients undergoing dialysis: A systematic review and meta-analysis. | Heliyon | 2023 | 37123954 | PubTator, text mining | PubMed |
| Erythropoietin and Erythropoietin Receptor Levels and Their Diagnostic Values in Drug-naïve Patients with Generalized Anxiety Disorder. | Clin Psychopharmacol Neurosci | 2023 | 37119221 | PubTator, text mining | PubMed |
| Iron-loaded deferiprone can support full hemoglobinization of cultured red blood cells. | Sci Rep | 2023 | 37117329 | PubTator, text mining | PubMed |
| Mesenchymal Stem/Stromal Cells in Skeletal Muscle Are Pro-Angiogenic, and the Effect Is Potentiated by Erythropoietin. | Pharmaceutics | 2023 | 37111534 | PubTator, text mining | PubMed |
| Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment. | Pharmaceuticals (Basel) | 2023 | 37111367 | PubTator, text mining | PubMed |
| Optic Neuropathies: Current and Future Strategies for Optic Nerve Protection and Repair. | Int J Mol Sci | 2023 | 37108140 | PubTator, text mining | PubMed |
| Iron Deficiency and Iron Deficiency Anemia: Potential Risk Factors in Bone Loss. | Int J Mol Sci | 2023 | 37108056 | PubTator, text mining | PubMed |
| Redox Imbalance in Neurological Disorders in Adults and Children. | Antioxidants (Basel) | 2023 | 37107340 | PubTator, text mining | PubMed |
| One gene, two opposite phenotypes: a case report of hereditary anemia due to a loss-of-function variant in the EPAS1 gene. | Haematologica | 2023 | 37102609 | PubTator, text mining | PubMed |
| Generation of Rh D-negative blood using CRISPR/Cas9. | Cell Prolif | 2023 | 37096780 | PubTator, text mining | PubMed |
| [Prognostic analysis of children with Philadelphia chromosome-like acute lymphoblastic leukemia common genes]. | Zhonghua Er Ke Za Zhi | 2023 | 37096265 | PubTator, text mining | PubMed |
| High intact fibroblast growth factor 23 levels associated with low hemoglobin levels in patients on chronic hemodialysis. | Front Med (Lausanne) | 2023 | 37081846 | PubTator, text mining | PubMed |
| Electrochemical and Optical Sensors for the Detection of Chemical Carcinogens Causing Leukemia. | Sensors (Basel) | 2023 | 37050429 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2057/papers?page=17